Storia della carriera di Marie-Noëlle Ip
Precedenti posizioni note di Marie-Noëlle Ip
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BCE INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2003 |
| Council of Canadian Academies | Corporate Officer/Principal | - | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Direttore operativo | 01/05/2009 | - |
Statistiche
Distribuzione geografica
| Canada | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 2 |
| Communications | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BCE INC. | Communications |
| Aziende private | 2 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
| Council of Canadian Academies |
- Borsa valori
- Insiders
- Marie-Noëlle Ip
- Esperienza
